Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validation
暂无分享,去创建一个
Samuel W. K. Wong | Wanhua Su | John J. Chen | N. Miller | M. T. ten Hove | N. Nijhawan | F. Tyndel | Andrew Toren | N. Khalidi | C. Sheldon | V. Kansal | A. Nguyen | Amadeo R. Rodriguez | M. Lee-Wing | M. Gans | Edsel Ing | Royce Ing | L. Bellan | N. Torun | Angela Hu | M. Shields | A. Sundaram | Dongho Lee | Y. Mohadjer | Colten Wendel | J. Mouhanna | Lulu L C D Bursztyn | M. Poole | Dana Albreki | Alla Muladzanov | Mikaël Bernier | L. Bursztyn | N. Miller
[1] Miguel Angel Luque-Fernandez,et al. cvauroc: Command to compute cross-validated area under the curve for ROC analysis after predictive modeling for binary outcomes , 2019, The Stata Journal: Promoting communications on statistics and Stata.
[2] Matthias Schonlau,et al. Support Vector Machines and logistic regression to predict temporal artery biopsy outcomes. , 2019, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[3] D. Munoz,et al. The incidence of giant cell arteritis in Ontario, Canada. , 2019, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[4] A. Kirubarajan,et al. Systematic Review of the Yield of Temporal Artery Biopsy for Suspected Giant Cell Arteritis , 2018, Neuro-ophthalmology.
[5] A. Aouba,et al. Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980–2011) , 2018, Rheumatology.
[6] A. Gill,et al. Value of temporal artery biopsy length in diagnosing giant cell arteritis , 2018, ANZ journal of surgery.
[7] Edsel Ing,et al. The Use of a Nomogram to Visually Interpret a Logistic Regression Prediction Model for Giant Cell Arteritis , 2018, Neuro-ophthalmology.
[8] A. Iagnocco,et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice , 2018, Annals of the rheumatic diseases.
[9] C. Pagnoux,et al. Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study , 2018, Clinical ophthalmology.
[10] P. Ranalli,et al. Lower ocular pulse amplitude with dynamic contour tonometry is associated with biopsy-proven giant cell arteritis. , 2017, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[11] E. Weis,et al. Development of a predictive model for temporal artery biopsies. , 2017, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[12] John J. Chen,et al. Multivariable prediction model for suspected giant cell arteritis: development and validation , 2017, Clinical ophthalmology.
[13] H. Danesh-Meyer,et al. New developments in giant cell arteritis. , 2016, Survey of ophthalmology.
[14] Ewout W Steyerberg,et al. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests , 2016, British Medical Journal.
[15] Gary S Collins,et al. Sample size considerations for the external validation of a multivariable prognostic model: a resampling study , 2015, Statistics in medicine.
[16] M. El-Dairi,et al. Diagnostic Algorithm for Patients With Suspected Giant Cell Arteritis , 2015, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[17] C. Kaufmann,et al. Ocular pulse amplitude as a diagnostic adjunct in giant cell arteritis , 2015, Eye.
[18] B. van Calster,et al. Calibration of Risk Prediction Models , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.
[19] G. Collins,et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC Medicine.
[20] G. Rebolleda,et al. A calculator for temporal artery biopsy result prediction in giant cell arteritis suspects. , 2014, European journal of internal medicine.
[21] M. Sarossy,et al. The use of statistical modeling to predict temporal artery biopsy outcome from presenting symptoms and laboratory results , 2014 .
[22] A. Godra,et al. Polyangiitis overlap syndrome with granulomatosis with polyangiitis (Wegener's) and giant cell arteritis. , 2013, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[23] A. Karthikesalingam,et al. Importance of specimen length during temporal artery biopsy , 2011, The British journal of surgery.
[24] K. Barraclough,et al. BSR and BHPR guidelines for the management of giant cell arteritis. , 2010, Rheumatology.
[25] R. Nesher,et al. Rate of Discordant Findings in Bilateral Temporal Artery Biopsy to Diagnose Giant Cell Arteritis , 2009, The Journal of Rheumatology.
[26] S. Scherer,et al. Race and ancestry in biomedical research: exploring the challenges , 2009, Genome Medicine.
[27] H. Raspe,et al. EULAR recommendations for the management of large vessel vasculitis , 2008, Annals of the rheumatic diseases.
[28] R. L. Font,et al. Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases , 2006, British Journal of Ophthalmology.
[29] J Coste,et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? , 2006, Annals of the rheumatic diseases.
[30] Patrick Royston,et al. The cost of dichotomising continuous variables , 2006, BMJ : British Medical Journal.
[31] Ryan D Niederkohr,et al. Management of the patient with suspected temporal arteritis a decision-analytic approach. , 2005, Ophthalmology.
[32] Yvonne Vergouwe,et al. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. , 2005, Journal of clinical epidemiology.
[33] R. Cooper,et al. Commentary: considerations for use of racial/ethnic classification in etiologic research. , 2001, American journal of epidemiology.
[34] R. Malhotra,et al. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. , 2000, American journal of ophthalmology.
[35] S. Hayreh,et al. Occult giant cell arteritis: ocular manifestations. , 1998, American journal of ophthalmology.
[36] J. Leavitt,et al. Systemic amyloidosis with temporal artery involvement mimicking temporal arteritis. , 1997, Ophthalmic surgery and lasers.
[37] J V Tu,et al. Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. , 1996, Journal of clinical epidemiology.
[38] M L Astion,et al. Application of neural networks to the classification of giant cell arteritis. , 1994, Arthritis and rheumatism.
[39] Javier Martín,et al. Genetic component of giant cell arteritis. , 2014, Rheumatology.
[40] Oguzhan Alagoz,et al. Informatics in radiology: comparison of logistic regression and artificial neural network models in breast cancer risk estimation. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.
[41] E. L. Kelly. Clinical versus statistical prediction: A theoretical analysis and review of the evidence. , 1955 .